2
Clinical Trials associated with Teneligliptin Hydrobromide Hydrate/Metformin HydrochlorideA Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Evaluate the Effect of Food on the Safety and Pharmacokinetics of Fixed-dose Combination of MP-513 10mg and Metformin XR 750mg in Healthy Male Volunteers
The purpose of this study is to compare the safety and pharmacokinetic characteristics of fixed-dose combination of MP-513 10mg and metformin XR 750mg administered in a high fat fed state versus fasting state to healthy male volunteers.
A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of FDC of MP-513 20mg and Metformin XR 1000mg With Coadministration of the Two Separate Drugs in Healthy Male Volunteers
The purpose of this study is to compare the safety and pharmacokinetic characteristics of fixed-dose combination of MP-513 20mg and Metformin XR 1000mg with coadministration of the two separate drugs in healthy male volunteers.
100 Clinical Results associated with Teneligliptin Hydrobromide Hydrate/Metformin Hydrochloride
100 Translational Medicine associated with Teneligliptin Hydrobromide Hydrate/Metformin Hydrochloride
100 Patents (Medical) associated with Teneligliptin Hydrobromide Hydrate/Metformin Hydrochloride
100 Deals associated with Teneligliptin Hydrobromide Hydrate/Metformin Hydrochloride